Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online October 1, 2020.
Article Versions
- Latest version (April 1, 2020 - 03:59).
- You are currently viewing a Latest version of this article (October 1, 2020 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2020 The Journal of Rheumatology
Author Information
- Murray B. Urowitz,
- Dafna D. Gladman,
- Dominique Ibañez,
- Jiandong Su,
- Sara Mursleen,
- Amyn Sayani,
- Jorge Alfonso Ross Terres and
- Sandra Iczkovitz
- This study was funded by GlaxoSmithKline Inc. (GSK; study number 201390).
M.B. Urowitz, MD, D.D. Gladman, MD, D. Ibañez, MSc, J. Su, MSc, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada; 2S. Mursleen, MSc, A. Sayani, PhD, S. Iczkovitz, MSc, GlaxoSmithKline Inc., Toronto, Ontario, Canada; 3J.A.R. Terres, MD, GlaxoSmithKline Inc., Toronto, Ontario, Canada, and GlaxoSmithKline Inc., Philadelphia, Pennsylvania, USA.
JART and SM are employees of GSK. AS was an employee of GSK at the time of the study. AS and JART hold stocks in GSK. SI was an employee of GSK during the development of the manuscript. MBU has received consulting fees and research grants from GSK, UCB, and Eli Lilly. DDG reports consulting for GSK, BMS, Janssen, UCB, and Eli Lilly. Address correspondence to Prof. M.B. Urowitz, Toronto Western Hospital, 399 Bathurst Street, 1E409, Toronto, ON M5T 2S8, Canada. Email: m.urowitz@utoronto.ca.
Full Release Article. For details see Reprints/Permissions at jrheum.org.
Accepted for publication March 18, 2020.